Changes in haematological variables with one-year treatment with pioglitazone, metformin and gliclazide in 3713 type 2 diabetic patients

被引：0
|
作者：
Belcher, G
Edwards, G
Urquhart, R
Eckland, D
Tan, M
Herz, M
机构：
来源：
DIABETES | 2003年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A111 / A111
页数：1
相关论文
共 50 条
  • [21] Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients
    Chen, Lu-lu
    Liao, Yun-fei
    Zeng, Tian-shu
    Yu, Fan
    Li, Hui-qing
    Feng, Yong
    ENDOCRINE, 2010, 38 (02) : 266 - 275
  • [22] Serum sialic acid changes in type 2 diabetic patients on metformin or rosiglitazone treatment
    Rahman, I. U.
    Malik, S. A.
    Bashir, M.
    Khan, R. U.
    Idrees, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (06) : 685 - 690
  • [23] Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients
    Lu-lu Chen
    Yun-fei Liao
    Tian-shu Zeng
    Fan Yu
    Hui-qing Li
    Yong Feng
    Endocrine, 2010, 38 : 266 - 275
  • [24] A comparision of the efficacy of pioglitazone plus sulphonylurea with metformin plus sulphonylurea over one year in patients with type 2 diabetes
    Maher, L
    Edwards, G
    Lee, C
    Tan, M
    Herz, M
    DIABETES, 2003, 52 : A451 - A451
  • [25] Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study
    Matthews, DR
    Charbonnel, BH
    Hanefeld, M
    Brunetti, P
    Schernthaner, G
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2005, 21 (02) : 167 - 174
  • [26] Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin
    Araki, Takahiro
    Emoto, Masanori
    Teramura, Megumi
    Yokoyama, Hisayo
    Mori, Katsuhito
    Hatsuda, Sawako
    Maeno, Takaaki
    Shinohara, Kayo
    Koyama, Hidenori
    Shoji, Tetsuo
    Inaba, Masaaki
    Nishizawa, Yoshiki
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2006, 55 (08): : 996 - 1001
  • [27] A comparison of the efficacy of pioglitazone plus sulphonylurea with metformin plus sulphonylurea over one year in patients with Type 2 diabetes.
    Lee, C
    Edwards, GC
    Maher, LJ
    Urquhart, R
    Tan, M
    DIABETOLOGIA, 2003, 46 : A61 - A61
  • [28] Effects of Metformin on the Cerebral Metabolic Changes in Type 2 Diabetic Patients
    Huang, Yung-Cheng
    Hsu, Chien-Chin
    Lin, Wei-Che
    Yin, Tang-Kai
    Huang, Chi-Wei
    Wang, Pei-Wen
    Chang, Han-Hsuan
    Chiu, Nan-Tsing
    SCIENTIFIC WORLD JOURNAL, 2014,
  • [29] ONE-YEAR COMPARATIVE TRIAL OF METFORMIN AND GLIPIZIDE IN TYPE-2 DIABETES-MELLITUS
    CAMPBELL, IW
    MENZIES, DG
    CHALMERS, J
    MCBAIN, AM
    BROWN, IRF
    DIABETES & METABOLISM, 1994, 20 (04): : 394 - 400
  • [30] Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin
    Derosa, Giuseppe
    Fogari, Elena
    Cicero, Arrigo F. G.
    D'Angelo, Angela
    Ciccarelli, Leonardina
    Piccinni, Mario N.
    Pricolo, Fabio
    Salvadeo, Sibilla A. T.
    Gravina, Alessia
    Ferrari, Ilaria
    Fogari, Roberto
    HYPERTENSION RESEARCH, 2007, 30 (05) : 387 - 394
12345